Top-Rated Charity
Website
View similar charities
Ratings & Metrics
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Richard Killian | Project Director | $348,270 |
| 2 | Gary Camus | CFO | $298,534 |
| 3 | Paul Perchal | VP | $266,092 |
|
1 Name: Richard Killian Title: Project Director Compensation: $348,270 |
|
2 Name: Gary Camus Title: CFO Compensation: $298,534 |
|
3 Name: Paul Perchal Title: VP Compensation: $266,092 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
| According to the EngenderHealth audit of June 30, 2017 (Note 3, Concentration of Credit Risk): "... Total contributions and private grants revenue received from one donor aggregate to 78% and 42% during 2017 and 2016, respectively..." |
| According to the EngenderHealth audit of June 30, 2017 (Note 11(b), Commitments and Contingencies): "EngenderHealth receives funding from U.S government agencies, primarily USAID, and other organizations for various activities which are subject to audits. Although such audits may result in disallowance of certain expenditures, which would be absorbed by EngenderHealth, in management's opinion, the ultimate outcome of such audits would not have a material effect on the financial position, changes in net assets, or cash flows of EngenderHealth. "At June 30, 2017, accounts payable and accrued expenses...include reserves totaling $270,965, which represent management's estimate of amounts related to an ongoing audit and notice of disallowance on its Kenya/APHIA project. In April 2013, EngenderHealth received a revised audit report commissioned by USAID Kenya regarding the Kenya/APHIA project indicating questioned costs totaling $1,362,121. EngenderHealth submitted a formal response to the original audit report on August 3, 2013 stating their position that the questioned costs were principally allowable. On February 28, 2014, the USAID/Kenya Agreement Officer issued a Final Decision to sustain the full amount of $1,362,121 as disallowed. On March 28, 2014, EngenderHealth submitted a formal appeal of the Final Decision to USAID/Washington, contesting $1,253,297 of the disallowance and conceding a disallowance of $108,824. As of June 30, 2017 EngenderHealth continues to believe that it has made adequate provisions for the liabilities likely to arise although the ultimate liability is dependent upon the outcome of the agreement with the relevant authority or litigation where appropriate." |